Patent search ap:("Exelixis Page Inc.") AND inv:"Linh Nguyen"

1.

发明申请
Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 审中-公开

公开(公告)号：US20190218182A1

公开(公告)日：2019-07-18

申请号：US16362863

申请日：2019-03-25

Applicant: Exelixis, Inc.

Inventor： Dana T. Aftab , Sriram Naganathan , Wei Xu , Steven Lacy , Linh Nguyen

IPC: C07D215/22 , G01N33/487 , C07C233/60 , C07C305/24 , C07D215/60

CPC classification number: C07D215/22 , C07C233/60 , C07C305/24 , C07C2601/02 , C07D215/60 , G01N33/487 , G01N2570/00

Abstract: The invention relates to metabolites of cabozantinib (I) as well as uses thereof.

2.

发明授权
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 有权

公开(公告)号：US10273211B2

公开(公告)日：2019-04-30

申请号：US14776337

申请日：2014-03-17

Applicant: Exelixis, Inc.

Inventor： Dana T. Aftab , Sriram Naganathan , Wei Xu , Steven Lacy , Linh Nguyen

IPC: C07D215/22 , C07C305/24 , C07C233/60 , C07D215/60 , G01N33/487

Abstract: The invention relates to metabolites of cabozantinib (I) as well as uses thereof.

3.

发明公开
METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE 审中-公开

公开(公告)号：US20240287002A1

公开(公告)日：2024-08-29

申请号：US18641587

申请日：2024-04-22

Applicant: Exelixis, Inc.

Inventor： Dana T. Aftab , Sriram Naganathan , Wei Xu , Steven Lacy , Linh Nguyen

IPC: C07D215/22 , C07C233/60 , C07C305/24 , C07D215/60 , G01N33/487

CPC classification number: C07D215/22 , C07C233/60 , C07C305/24 , C07D215/60 , G01N33/487 , C07C2601/02 , G01N2570/00

Abstract: The invention relates to metabolites of cabozantinib (I) as well as uses thereof.

4.

发明申请
Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 有权

公开(公告)号：US20210002228A1

公开(公告)日：2021-01-07

申请号：US17031196

申请日：2020-09-24

Applicant: Exelixis, Inc.

Inventor： Dana T. Aftab , Sriram Naganathan , Wei Xu , Steven Lacy , Linh Nguyen

IPC: C07D215/22 , C07C305/24 , C07C233/60 , C07D215/60 , G01N33/487

Abstract: The invention relates to metabolites of cabozantinib (I) as well as uses thereof.

5.

发明申请
Metabolites of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 审中-公开
Title translation: N-（4-苯基）-N' - （4-氟苯基）环丙烷-1,1-二甲酰胺的代谢物

公开(公告)号：US20160031818A1

公开(公告)日：2016-02-04

申请号：US14776337

申请日：2014-03-17

Applicant: Exelixis, Inc.

Inventor： Dana T. Aftab , Sriram Naganathan , Wei Xu , Steven Lacy , Linh Nguyen

IPC: C07D215/22 , G01N33/487 , C07D215/60

CPC classification number: C07D215/22 , C07C233/60 , C07C305/24 , C07C2601/02 , C07D215/60 , G01N33/487 , G01N2570/00

Abstract: The invention relates to metabolites of cabozantinib (I) as well as uses thereof.

Abstract translation: 本发明涉及卡泊沙坦（I）的代谢物及其用途。

Patent Agency Ranking